Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I FINK

Showing results (31-40 of 45) with videos related to

Pageof 5
Sort By:
Il Farmaco; Edizione Scientifica|December 1, 1980
The quantitative structure-selectivity relationship of anthracycline antitumor activity and cardiac toxicityS I Fink, A Leo, M Yamakawa, et al.
The British Journal of Ophthalmology|April 1, 1988
Therapeutic limitations of argon laser trabeculoplastyA I Fink, A J Jordan, P N Lao, et al.
The American Journal of Cardiology|September 15, 1986
Use of maximal bicycle exercise testing with respiratory gas analysis to assess exercise performance in patients with congestive heart failure secondary to coronary artery disease or to idiopathic dilated cardiomyopathyJ R Wilson, L I Fink, N Ferraro, et al.
Pediatric Research|December 1, 1991
Ontogeny of surfactant proteins A and B in human amniotic fluid as indices of fetal lung maturityG S Pryhuber, W M Hull, I Fink, et al.
VASA. Zeitschrift Fur Gefasskrankheiten|September 28, 2005
Behcet's disease is associated with increased concentrations of antibodies against phosphatidylserine and ribosomal phosphoproteinsP Berlit, B Stueper, I Fink, et al.
Diabetes|December 1, 1989
Effects of aging on insulin secretionB Gumbiner, K S Polonsky, W F Beltz, et al.
Circulation|June 1, 1986
Abnormal skeletal muscle bioenergetics during exercise in patients with heart failure: role of reduced muscle blood flowD H Wiener, L I Fink, J Maris, et al.
The Journal of Biological Chemistry|December 5, 1990
Phorbol ester inhibits surfactant protein SP-A and SP-B expressionG S Pryhuber, M A O'Reilly, J C Clark, et al.
American Journal of Hematology|February 19, 2000
Activated recombinant human coagulation factor VII (rFVIIa) therapy for abdominal bleeding in patients with inhibitory antibodies to factor VIIIH A Liebman, J Chediak, K I Fink, et al.
Infection|July 18, 2002
Hepatitis B vaccination: long-term follow-up of the immune response of preterm infants and comparison of two vaccination protocolsN Linder, T H Vishne, E Levin, et al.
Pageof 5

Showing results (31-40 of 45) with videos related to

Sort By:
Pageof 5
Il Farmaco; Edizione Scientifica|December 1, 1980
The quantitative structure-selectivity relationship of anthracycline antitumor activity and cardiac toxicityS I Fink, A Leo, M Yamakawa, et al.
The British Journal of Ophthalmology|April 1, 1988
Therapeutic limitations of argon laser trabeculoplastyA I Fink, A J Jordan, P N Lao, et al.
The American Journal of Cardiology|September 15, 1986
Use of maximal bicycle exercise testing with respiratory gas analysis to assess exercise performance in patients with congestive heart failure secondary to coronary artery disease or to idiopathic dilated cardiomyopathyJ R Wilson, L I Fink, N Ferraro, et al.
Pediatric Research|December 1, 1991
Ontogeny of surfactant proteins A and B in human amniotic fluid as indices of fetal lung maturityG S Pryhuber, W M Hull, I Fink, et al.
VASA. Zeitschrift Fur Gefasskrankheiten|September 28, 2005
Behcet's disease is associated with increased concentrations of antibodies against phosphatidylserine and ribosomal phosphoproteinsP Berlit, B Stueper, I Fink, et al.
Diabetes|December 1, 1989
Effects of aging on insulin secretionB Gumbiner, K S Polonsky, W F Beltz, et al.
Circulation|June 1, 1986
Abnormal skeletal muscle bioenergetics during exercise in patients with heart failure: role of reduced muscle blood flowD H Wiener, L I Fink, J Maris, et al.
The Journal of Biological Chemistry|December 5, 1990
Phorbol ester inhibits surfactant protein SP-A and SP-B expressionG S Pryhuber, M A O'Reilly, J C Clark, et al.
American Journal of Hematology|February 19, 2000
Activated recombinant human coagulation factor VII (rFVIIa) therapy for abdominal bleeding in patients with inhibitory antibodies to factor VIIIH A Liebman, J Chediak, K I Fink, et al.
Infection|July 18, 2002
Hepatitis B vaccination: long-term follow-up of the immune response of preterm infants and comparison of two vaccination protocolsN Linder, T H Vishne, E Levin, et al.
Pageof 5